Correction to: Bone Marrow Transplantation https://doi.org/10.1038/s41409-022-01820-5, published online 03 November 2022
The information to Supplementary Table 2 was given by mistake as Supplementary Table 1 in the sentence: The remaining two patients did not meet the narrow definition of engraftment used in this study (neutrophil count ≥500/mm3 for 3 consecutive days), but both patients did achieve a neutrophil count ≥500/mm3 on multiple non-consecutive days after autologous HSCT (Supplementary Table S2).
In addition Supplementary Table 1 was missing from this article and has now been uploaded.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hara, J., Matsumoto, K., Maeda, N. et al. Correction: High-dose thiotepa, in conjunction with melphalan, followed by autologous hematopoietic stem cell transplantation in patients with pediatric solid tumors, including brain tumors. Bone Marrow Transplant 58, 238 (2023). https://doi.org/10.1038/s41409-022-01890-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41409-022-01890-5
